Clinical Trials in Phoenix

Showing 12321-12340 of 14,291 trials

A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

NCT02125578

The primary objectives are to identify the highest safe and well-tolerated dose and frequency of BIIB017 (PEGylated Interferon Beta-1a) subcutaneous (SC), within the range of 63 to 188 mcg, when given every other week or every 4 weeks to healthy volunteers (HV).

Healthy

Biogen69 participantsStarted Mar 2008

Phoenix, Arizona, United States

COMPLETEDPhase 3< 1 mile

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

NCT00403767

The purpose of this study is to compare the efficacy and safety of rivaroxaban with warfarin for the prevention of blood clots in the brain (referred to as stroke) and blood clots in other parts of the body referred to as non-central nervous system systemic embolism) in patients with non-valvular atrial fibrillation (a heart rhythm disorder).

Atrial FibrillationStrokeEmbolism

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.14,269 participantsStarted Dec 2006

Birmingham, Alabama, United States • Dothan, Alabama, United States • Geneva, Alabama, United States +929 more locations

A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Find Trials by Condition in Phoenix

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

CRx-102 Osteoarthritis Multicenter Evaluation Trial

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Clinical Trial of CNS-targeted HAART (CIT2)

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Spondylolisthesis Treated With an iO-Flex® System Enabled Decompression

A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)

An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer